Related Experiment Videos
MMP-2 and 9 in Chronic Kidney Disease
Zhengyuan Cheng1, Manoj Hang Limbu2, Zhi Wang3
1Department of Pathology and Pathophysiology, Medical School, Southeast University, Dingjiaqiao 87, Gulou District, Nanjing 210009, China. 230159257@seu.edu.cn.
International Journal of Molecular Sciences
|April 12, 2017
Summary
Gelatinases, part of the matrix metalloproteinase (MMPs) family, are key in extracellular matrix degradation and chronic kidney disease (CKD) progression. Understanding their functions, including non-proteolytic roles, offers insights into CKD development.
Area of Science:
- Biochemistry
- Cell Biology
- Nephrology
Background:
- Gelatinases are matrix metalloproteinases (MMPs) involved in extracellular matrix (ECM) degradation.
- ECM degradation is critical in the development and progression of chronic kidney disease (CKD).
Purpose of the Study:
- To explore the multifaceted roles of gelatinases in CKD.
- To highlight the connection between gelatinase activity, cell signaling, and CKD pathogenesis.
- To investigate the emerging non-proteolytic functions of gelatinases in relation to CKD.
Main Methods:
- Literature review of studies on gelatinases and CKD.
- Analysis of cell signaling pathways, hypoxia, and membrane changes related to gelatinase expression.
- Examination of interactions between gelatinases and factors like TNFs, MCPs, GFs, and oxidative stress in CKD.
Main Results:
- Gelatinase expression and activity are linked to CKD progression via cell signaling, hypoxia, and membrane changes.
- Interactions with TNFs, MCPs, GFs, and oxidative stress influence CKD development.
- Non-proteolytic functions of gelatinases are increasingly recognized as relevant to CKD.
Conclusions:
- Gelatinases play a significant role in the pathophysiology of chronic kidney disease.
- A comprehensive understanding of gelatinase functions, including non-proteolytic activities, is essential for advancing CKD research.
- Targeting gelatinase pathways may offer novel therapeutic strategies for CKD.